Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT00768560
Eligibility Criteria:
Inclusion Criteria:
* Male and female
* 20 years or older and less than 75 years
* Outpatient
* Untreated or treated patients with antihypertensive agents whose blood pressure (BP) in sitting position at entry (Visit 1) is as follows.
* Untreated patients: systolic blood pressure (SBP) \>= 160mmHg or diastolic blood pressure (DBP) \>= 100mmHg
* Treated patients: SBP \>= 140mmHg or DBP \>= 90mmHg (at trough)
Exclusion Criteria:
* Patients whose BP during baseline treatment period is: SBP\>=200mmHg or DBP\>=120mmHg.
* Patients with secondary hypertension or hypertensive emergency.
* Patients with cardiovascular or cerebrovascular ischemic event (stroke, transient ischemic attack (TIA), myocardial infarction or unstable angina), or with history of these within 6 months prior to the study.
* Patients with intracranial or subarachnoid hemorrhage, or with history of these within 6 months prior to the study.
* Patients with server hematopoietic dysfunction (acute/chronic leukemia, myeloma, malignant lymphoma, myelodysplastic syndrome, aplastic anemia), or with history of these.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT00768560
Study Brief:
Protocol Section:
NCT00768560